Principal Financial Group
LFCR icon

Principal Financial Group’s Lifecore Biomedical LFCR Stock Holding History

Principal Financial Group’s Portfolio LFCR Stock Details LFCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-149,600
Closed -$1.67M – 2270
2014
Q1 		$1.67M Sell
149,600
-28,800
-16% -$316K ﹤0.01% 1687
2013
Q4 		$2.16M Sell
178,400
-1,341
-0.7% -$16K ﹤0.01% 1651
2013
Q3 		$2.19M Buy
179,741
+6,563
+4% +$91.6K ﹤0.01% 1612
2013
Q2 		$2.29M Buy
+173,178
New +$2.39M 0.01% 1562

Other funds holding LFCR

GC
Guggenheim Capital Chicago, Illinois $12.9B AUM 27.3% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
OCG
Opus Capital Group Cincinnati, Ohio $930M AUM 16.14% 1-Year Est. Return
WC
Wynnefield Capital New York $148M AUM 32.71% 1-Year Est. Return
KG
Killen Group Berwyn, Pennsylvania $866M AUM 0.25% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Principal Financial Group's LFCR Position: Q2 2014 in Review

Principal Financial Group sold out of Lifecore Biomedical (LFCR) in Q2 2014, closing a stake of 149,600 shares — an estimated $1.67M sold.

Principal Financial Group first reported a position in LFCR in Q2 2013 and held it in 4 quarters. The position peaked at $2.29M in Q2 2013. 101 funds tracked by Wall St. Rank hold LFCR as of Q2 2014.

  • Principal Financial Group reported no remaining Lifecore Biomedical position as of Q2 2014 after selling out during the quarter.
  • Principal Financial Group sold 149,600 Lifecore Biomedical shares in Q2 2014, an estimated $1.67M.
  • Principal Financial Group first reported a position in Lifecore Biomedical in Q2 2013 and held it in 4 quarters.
  • Principal Financial Group's Lifecore Biomedical position peaked at $2.29M in Q2 2013.
  • 101 funds tracked by Wall St. Rank held Lifecore Biomedical as of Q2 2014.

Based on Principal Financial Group's 13F filing for Q2 2014, filed 12 Aug 2014.